Free Trial

Spectral AI (MDAI) Competitors

Spectral AI logo
$1.97 -0.16 (-7.51%)
Closing price 04:00 PM Eastern
Extended Trading
$2.05 +0.08 (+3.86%)
As of 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MDAI vs. NVRO, SGHT, DRTS, TLSI, BWAY, SKIN, AVR, LAKE, INGN, and PROF

Should you be buying Spectral AI stock or one of its competitors? The main competitors of Spectral AI include Nevro (NVRO), Sight Sciences (SGHT), Alpha Tau Medical (DRTS), TriSalus Life Sciences (TLSI), BrainsWay (BWAY), Beauty Health (SKIN), Anteris Technologies Global (AVR), Lakeland Industries (LAKE), Inogen (INGN), and Profound Medical (PROF). These companies are all part of the "medical equipment" industry.

Spectral AI vs. Its Competitors

Nevro (NYSE:NVRO) and Spectral AI (NASDAQ:MDAI) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, community ranking, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Spectral AI has lower revenue, but higher earnings than Nevro. Spectral AI is trading at a lower price-to-earnings ratio than Nevro, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nevro$408.52M0.55-$92.21M-$3.05-1.92
Spectral AI$29.96M1.66-$20.85M-$0.54-3.65

Nevro presently has a consensus price target of $5.36, indicating a potential downside of 8.29%. Spectral AI has a consensus price target of $4.75, indicating a potential upside of 141.12%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts plainly believe Spectral AI is more favorable than Nevro.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nevro
2 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.92
Spectral AI
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

Nevro has a net margin of -16.54% compared to Spectral AI's net margin of -40.78%. Spectral AI's return on equity of 0.00% beat Nevro's return on equity.

Company Net Margins Return on Equity Return on Assets
Nevro-16.54% -23.52% -10.83%
Spectral AI -40.78%N/A -77.87%

Nevro received 497 more outperform votes than Spectral AI when rated by MarketBeat users. However, 87.50% of users gave Spectral AI an outperform vote while only 62.07% of users gave Nevro an outperform vote.

CompanyUnderperformOutperform
NevroOutperform Votes
504
62.07%
Underperform Votes
308
37.93%
Spectral AIOutperform Votes
7
87.50%
Underperform Votes
1
12.50%

Nevro has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, Spectral AI has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500.

95.5% of Nevro shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 3.2% of Nevro shares are owned by company insiders. Comparatively, 30.7% of Spectral AI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Spectral AI had 3 more articles in the media than Nevro. MarketBeat recorded 4 mentions for Spectral AI and 1 mentions for Nevro. Spectral AI's average media sentiment score of 0.89 beat Nevro's score of 0.00 indicating that Spectral AI is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nevro
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Spectral AI
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Spectral AI beats Nevro on 13 of the 19 factors compared between the two stocks.

Get Spectral AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDAI vs. The Competition

MetricSpectral AISurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$49.87M$4.32B$5.58B$8.50B
Dividend YieldN/A42.67%5.28%4.17%
P/E Ratio-3.0327.8327.1919.64
Price / Sales1.6668.29408.78152.17
Price / CashN/A51.0838.3234.64
Price / Book-19.705.746.974.60
Net Income-$20.85M$66.95M$3.23B$248.06M
7 Day Performance-1.50%-2.83%-0.88%-1.02%
1 Month Performance38.73%14.77%7.81%3.51%
1 Year Performance23.90%17.94%31.53%12.68%

Spectral AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDAI
Spectral AI
3.6358 of 5 stars
$1.97
-7.5%
$4.75
+141.1%
+26.8%$49.87M$29.96M-3.0383Short Interest ↓
Gap Up
NVRO
Nevro
0.1592 of 5 stars
$5.85
+0.1%
$5.36
-8.3%
-38.1%$224.32M$408.52M-3.091,090
SGHT
Sight Sciences
1.4095 of 5 stars
$4.06
-3.3%
$4.02
-1.1%
-38.6%$217.12M$78.11M-3.98210
DRTS
Alpha Tau Medical
2.9215 of 5 stars
$3.13
+3.6%
$8.00
+155.6%
+32.3%$212.55MN/A-7.2880High Trading Volume
TLSI
TriSalus Life Sciences
3.6353 of 5 stars
$5.59
+3.7%
$10.75
+92.3%
-8.8%$211.52M$32.14M-2.24106Positive News
Short Interest ↓
Analyst Revision
BWAY
BrainsWay
2.9566 of 5 stars
$11.01
+5.4%
$14.25
+29.4%
+83.0%$207.90M$43.46M110.11120Gap Down
SKIN
Beauty Health
0.2693 of 5 stars
$1.60
flat
$1.42
-11.5%
-24.6%$201.59M$322.47M-3.811,030
AVR
Anteris Technologies Global
N/A$5.37
+13.3%
$16.50
+207.3%
N/A$193.65M$2.70M0.00138Lockup Expiration
Analyst Revision
LAKE
Lakeland Industries
4.9582 of 5 stars
$19.36
+7.4%
$27.33
+41.2%
-31.2%$184.13M$167.21M-215.111,800Trending News
Earnings Report
Analyst Forecast
Analyst Revision
High Trading Volume
INGN
Inogen
4.1063 of 5 stars
$6.64
+0.8%
$9.50
+43.1%
-23.8%$178.53M$339.96M-2.951,030Positive News
PROF
Profound Medical
2.5619 of 5 stars
$5.75
+3.2%
$11.50
+100.0%
-30.7%$172.81M$11.86M-4.29150Positive News

Related Companies and Tools


This page (NASDAQ:MDAI) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners